Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application

Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application

US Patent 10912849 · Granted Feb 9, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

F-18 labeled chiral pure derivative of hydroxyfuran, preparation method and use 2024
Deuterium substituted positron emission tomography (PET) imaging agents and thei2021
Deuterium substituted positron emission tomography (PET) imaging agents and thei2021
Deuterium substituted positron emission tomography (PET) imaging agents and thei2021
Deuterium substituted positron emission tomography (PET) imaging agents and thei2021
Deuterium substituted positron emission tomography (PET) imaging agents and thei2021
Deuterium substituted positron emission tomography (PET) imaging agents and thei2021
Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and 2020
Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and 2020
Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and 2020
Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and 2020
Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and 2020